Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information

The Story of Rucaparib, a 25 year journey to an anticancer drug

11 March 2020 14:00-15:00, Hull, United Kingdom

In 1989, Professor Gosling co-founded the anticancer drug discovery group at Newcastle that has become internationally recognised by virtue of its discoveries of inhibitors of numerous cancer-related targets, notably poly(ADP-ribose) polymerase (PARP-1). The PARP research led, in collaboration with Agouron Pharmaceuticals, to rucaparib (Rubraca), which recently acquired FDA and EMA approval for the treatment of BRCA-mutant ovarian cancer.

If you would like meet Professor Gosling please contact the seminar organiser.
University of Hull

Lecture Theatre C (third floor), Robert Blackburn Building (opp Chemistry), University of Hull, Cottingham Road, Hull, HU6 7RX, United Kingdom

  • Phil Caygill Hull & East Yorkshire Local Section, United Kingdom

Organised by
Dr Andrew Boa, Senior Lecturer in Organic Chemistry, Chemistry & Biochemistry Department, University of Hull.
Contact information
Showing all upcoming events
Start Date
End Date
Subject area
Event type


E-mail Enquiry